2. Academic Validation
  3. Sex differences in viral entry protein expression, host responses to SARS-CoV-2, and in vitro responses to sex steroid hormone treatment in COVID-19

Sex differences in viral entry protein expression, host responses to SARS-CoV-2, and in vitro responses to sex steroid hormone treatment in COVID-19

  • Res Sq. 2020 Nov 4;rs.3.rs-100914. doi: 10.21203/rs.3.rs-100914/v1.
Mengying Sun,  Rama Shankar,  Meehyun Ko,  Christopher Daniel Chang,  Shan-Ju Yeh,  Shilong Li,  Ke Liu,  Guoli Zhou,  Jing Xing,  Austin VanVelsen,  Tyler VanVelsen,  Shreya Paithankar,  Benjamin Y Feng,  Krista Young,  Michael Strug,  Lauren Turco,  Zichen Wang,  Eric Schadt,  Rong Chen,  Xiaohong Li,  Tomiko Oskotsky,  Marina Sirota,  Benjamin S Glicksberg,  Girish N Nadkarni,  Adam J Moeser,  Li Li,  Seungtaek Kim,  Jiayu Zhou,  Bin Chen
PMID: 33173861 DOI: 10.21203/rs.3.rs-100914/v1
Abstract

Epidemiological studies suggest that men exhibit a higher mortality rate to COVID-19 than women, yet the underlying biology is largely unknown. Here, we seek to delineate sex differences in the expression of entry genes ACE2 and TMPRSS2 , host responses to SARS-CoV-2, and in vitro responses to sex steroid hormone treatment. Using over 220,000 human gene expression profiles covering a wide range of age, tissues, and diseases, we found that male samples show higher expression levels of ACE2 and TMPRSS2 , especially in the older group (>60 years) and in the kidney. Analysis of 6,031 COVID-19 patients at Mount Sinai Health System revealed that men have significantly higher creatinine levels, an indicator of impaired kidney function. Further analysis of 782 COVID-19 patient gene expression profiles taken from upper airway and blood suggested men and women present profound expression differences in responses to SARS-CoV-2. Computational deconvolution analysis of these profiles revealed male COVID-19 patients have enriched kidney-specific mesangial cells in blood compared to healthy patients. Finally, we observed selective Estrogen Receptor modulators, but not other hormone drugs (agonists/antagonists of estrogen, androgen, and progesterone), could reduce SARS-CoV-2 Infection in vitro.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z